Effect of Obesity on the Pharmacokinetics of Drugs in Humans Michael J. HanleyDarrell R. AbernethyDavid J. Greenblatt Review Article 13 September 2012 Pages: 71 - 87
Bone Physiology, Disease and Treatment Teun M. PostSerge C. L. M. CremersMeindert Danhof Review Article 13 September 2012 Pages: 89 - 118
Population Pharmacokinetics and Pharmacodynamics of Cinaciguat, a Soluble Guanylate Cyclase Activator, in Patients with Acute Decompensated Heart Failure Wolfgang MueckReiner Frey Original Research Article 13 September 2012 Pages: 119 - 129
Predictive Performance of the ‘Minto’ Remifentanil Pharmacokinetic Parameter Set in Morbidly Obese Patients Ensuing from a New Method for Calculating Lean Body Mass Luca La CollaAndrea AlbertinFausto Gigli Original Research Article 13 September 2012 Pages: 131 - 139